Drug & medication recalls Moderate risk

HYDROmorphone HCl 10mg/ in 0 recalled over sterility concerns

Recall date
December 17, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
SCA Pharmaceuticals recalls HYDROmorphone HCl 10mg/50mL in 0.9% Sodium Chloride Injection, CII, Rx Only, 50 mL Single Dose Syringe, SCA Pharmaceuti…
Recall number
D-0215-2021
FDA classification
Class II
Brand / firm
SCA Pharmaceuticals
Sold / distributed
Product was distributed to hospitals nationwide.

Why it was recalled

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

HYDROmorphone HCl 10mg/50mL in 0.9% Sodium Chloride Injection, CII, Rx Only, 50 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004030022

Get recall alerts

Free email alert whenever SCA Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: SCA Pharmaceuticals